/blog/Blog_12.27.18_industrial-hemp-legalization-farm-bill_4.jpg

The passage of the 2018 Farm Bill on December 20 is a major step forward for the burgeoning cannabidiol (CBD) market. The bill legalizes industrial hemp, a variety of cannabis from which CBD can be extracted but does not produce mind-altering effects. Hemp has less than .3 percent of THC, which is the non-psychoactive component of cannabis.

There is a great deal of enthusiasm among professionals and product manufacturers about CBD and because of its demonstrated effectiveness in helping to reduce pain and inflammation and decrease pain signaling to the brain. Non mind altering or habit forming, CBD is absorbed through the skin where it binds to the body’s own CB2 receptors. It then connects with these receptors to provide anti-inflammatory pain relief.

Under the new law, hemp is removed from control by the Justice Department where had been regulated under the Controlled Substances Act and now is classified as a crop, falling under the supervision of the U.S. Department of Agriculture. However, the Food and Drug Administration will continue to regulate products containing cannabis or cannabis-derived products. From the FDA press release:

“…These changes include removing hemp from the Controlled Substances Act, which means that it will no longer be an illegal substance under federal law.

Just as important for the FDA and our commitment to protect and promote the public health is what the law didn’t change: Congress explicitly preserved the agency’s current authority to regulate products containing cannabis or cannabis-derived compounds under the Federal Food, Drug, and Cosmetic Act (FD&C Act) and section 351 of the Public Health Service Act. In doing so, Congress recognized the agency’s important public health role with respect to all the products it regulates. This allows the FDA to continue enforcing the law to protect patients and the public while also providing potential regulatory pathways for products containing cannabis and cannabis-derived compounds.”

Still the implications for the CBD industry are significant, with the expectation that there will be more investment in CBD to meet a growing consumer demand. CBD is now considered part of advanced clinical care and increasingly taking its place at the table of massage therapists, chiropractors and other medical professionals. In the consumer market, CBD also can be found in health products, pet snacks and supplements and beverages. Food manufacturers also are looking at CBD as an ingredient.

BIOTONE offerings

BIOTONE’s Lab+Blends introduced this year contain CBD. The product line, which includes a number of pain-relieving ingredients including menthol and lidocaine includes:

Professional Products:

Retail Products:

 

 

 

CBD treatment for holiday back pain

Decrease back pain caused by inflammation from all that holiday shopping with state-of-the-art clinical care containing active ingredients and powerful pain fighters. Lab Blends

Professional CBD Massage Cream allows for the ultimate massage with Precise Pain Relief.

 

Ingredient

Lab Blends 408mg CBD Massage Cream .................1/3 oz

 

Instructions

1. Position client on the massage table in a supine position.

2. Perform a gentle rocking compression from the shoulder to the hip.

3. Starting at the head of the table, apply a 5 second compression to the front of the chest. Slowly increase the pressure of the compression. Repeat movement down each

arm and along the lateral rib cage.

4. Squeeze a dime size amount of Lab Blends 408mg CBD Massage Cream into the palm of your hand. Rub hands together and then apply cream to client’s right arm from the wrist to the occipital ridge.

5. Perform 4 slow effleurage stokes from the wrist to the occipital ridge. Start with the hand palm down and rotate the arm with each successive stroke.

6. Perform 4 slow push/pull movements starting at the client’s wrist and moving to the shoulder.

7. Repeat 4 & 5 on the left side.

8. Perform 4 slow push/pull movements to the client’s abdominal area from the hip to just under the breast line. Jump over the breast tissue and continue movement on the upper chest.

9. Move to the head of the table. Apply long effleurage strokes from the shoulder to the occipital ridge. Repeat 6 times.

10. From a seated position, perform head rotations and push/ pull from the base of the neck to the occipital ridge.

11. Have client turn to a prone position.

12. Repeat 3 & 4 on the back.

13. Perform 4 slow push/pull movements from the client’s hip to upper back.

14. Move to the head of the table. Perform 4 slow, deep effleurage strokes from the occipital ridge to the sacrum.

15. Move to the right side. Perform 4 slow, deep effleurage strokes from the hip to the shoulder. Repeat on left side.

16. Perform slow rocking compressions with finger tips from sacrum to occipital ridge along the spine.

17. Finish with long slow connecting strokes from the occipital ridge to the sacrum